Spark Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Spark Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,800	Closed	-$401K	–	374
2020 Q1	$401K	Sell	11,800 -90,100	-88%	-$4.12M	0.21%	151
2019 Q4	$5.55M	Sell	101,900 -10,500	-9%	-$520K	0.65%	25
2019 Q3	$4.69M	Sell	112,400 -55,200	-33%	-$2.33M	0.6%	49
2019 Q2	$7.34M	Buy	167,600 +12,500	+8%	+$705K	0.51%	50
2019 Q1	$7.98M	Buy	155,100 +117,500	+313%	+$5.08M	0.37%	78
2018 Q4	$1.39M	Buy	+37,600	New	+$1.36M	0.1%	261

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spark Investment Management's BHVN Position: Q2 2020 in Review

Spark Investment Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2020, closing a stake of 11,800 shares — an estimated $401K sold.

Spark Investment Management first reported a position in BHVN in Q4 2018 and held it in 6 quarters. The position peaked at $7.98M in Q1 2019. 226 funds tracked by Wall St. Rank hold BHVN as of Q2 2020.

Spark Investment Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 11,800 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2020, an estimated $401K.
Spark Investment Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and held it in 6 quarters.
Spark Investment Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7.98M in Q1 2019.
226 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.